These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31272407)

  • 21. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables.
    Stojadinovic A; Leung DH; Allen P; Lewis JJ; Jaques DP; Brennan MF
    J Clin Oncol; 2002 Nov; 20(21):4344-52. PubMed ID: 12409334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.
    Mariani L; Miceli R; Kattan MW; Brennan MF; Colecchia M; Fiore M; Casali PG; Gronchi A
    Cancer; 2005 Jan; 103(2):402-8. PubMed ID: 15578681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External validation and adaptation of a dynamic prediction model for patients with high-grade extremity soft tissue sarcoma.
    Rueten-Budde AJ; van Praag VM; van de Sande MAJ; Fiocco M;
    J Surg Oncol; 2021 Mar; 123(4):1050-1056. PubMed ID: 33332599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic index for extremity soft tissue sarcomas with isolated local recurrence.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 2001 May; 8(4):278-89. PubMed ID: 11352300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall.
    Rutkowski P; Trepka S; Ptaszynski K; Kołodziejczyk M
    Clin Orthop Relat Res; 2013 Mar; 471(3):860-70. PubMed ID: 22972658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.
    Traweek RS; Lyu HG; Witt RG; Snyder RA; Nassif EF; Krijgh DD; Smith JM; Tilney GS; Feng C; Chiang YJ; Torres KE; Roubaud MJ; Scally CP; Hunt KK; Keung EZ; Mericli AF; Roland CL
    Ann Surg Oncol; 2024 Jun; 31(6):4138-4147. PubMed ID: 38396039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study.
    Ogura K; Fujiwara T; Yasunaga H; Matsui H; Jeon DG; Cho WH; Hiraga H; Ishii T; Yonemoto T; Kamoda H; Ozaki T; Kozawa E; Nishida Y; Morioka H; Hiruma T; Kakunaga S; Ueda T; Tsuda Y; Kawano H; Kawai A
    Cancer; 2015 Nov; 121(21):3844-52. PubMed ID: 26194185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do surgical margin and local recurrence influence survival in soft tissue sarcomas?
    Novais EN; Demiralp B; Alderete J; Larson MC; Rose PS; Sim FH
    Clin Orthop Relat Res; 2010 Nov; 468(11):3003-11. PubMed ID: 20645035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up after initial surgical treatment of soft tissue sarcomas in the extremities and trunk wall.
    Hovgaard TB; Nymark T; Skov O; Petersen MM
    Acta Oncol; 2017 Jul; 56(7):1004-1012. PubMed ID: 28287011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes.
    Potter BK; Hwang PF; Forsberg JA; Hampton CB; Graybill JC; Peoples GE; Stojadinovic A
    J Bone Joint Surg Am; 2013 Oct; 95(20):e151. PubMed ID: 24132366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma.
    Patel SA; Royce TJ; Barysauskas CM; Thornton KA; Raut CP; Baldini EH
    Ann Surg Oncol; 2017 Jun; 24(6):1588-1595. PubMed ID: 28058559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.
    Raut CP; Callegaro D; Miceli R; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss DC; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria S; Canter R; Mullen J; Gelderblom HJ; Pennacchioli E; van Coevorden F; Cardona K; Fiore M; Fairweather M; Gronchi A
    Clin Cancer Res; 2019 Apr; 25(8):2664-2671. PubMed ID: 30723141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
    Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
    Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC).
    van Praag VM; Rueten-Budde AJ; Jeys LM; Laitinen MK; Pollock R; Aston W; van der Hage JA; Dijkstra PDS; Ferguson PC; Griffin AM; Willeumier JJ; Wunder JS; van de Sande MAJ; Fiocco M
    Eur J Cancer; 2017 Sep; 83():313-323. PubMed ID: 28797949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma.
    Strong EA; Park SH; Ethun CG; Chow B; King D; Bedi M; Charlson J; Mogal H; Tsai S; Christians K; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Gamblin TC; Cardona K; Clarke CN
    Surgery; 2020 Oct; 168(4):760-767. PubMed ID: 32736869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
    Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
    Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limbs and trunk soft tissue sarcoma systematic local and remote monitoring by MRI and thoraco-abdomino-pelvic scanner: A single-centre retrospective study.
    De Angelis F; Guy F; Bertaut A; Méjean N; Varbedian O; Hervieu A; Truc G; Thibouw D; Barra CC; Fraisse J; Burnier P; Isambert N; Causeret S
    Eur J Surg Oncol; 2019 Jul; 45(7):1274-1280. PubMed ID: 30765271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors of primary resected retroperitoneal soft tissue sarcoma: Analysis from a single asian tertiary center and external validation of gronchi's nomogram.
    Chou YS; Liu CY; Chang YH; King KL; Chen PC; Pan CC; Shen SH; Liu YM; Lin AT; Chen KK; Shyr YM; Lee RC; Chao TC; Yang MH; Chan CH; You JY; Yen CC
    J Surg Oncol; 2016 Mar; 113(4):355-60. PubMed ID: 26749009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a Soft Tissue Sarcoma Nomogram Using a National Cancer Registry.
    Bagaria SP; Wagie AE; Gray RJ; Pockaj BA; Attia S; Habermann EB; Wasif N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S398-403. PubMed ID: 26353762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.
    Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H
    Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.